Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Unaudited financial results of the Company for the half year ended September 30, 2025 and to take note of the limited review report of the statutory auditors thereon.